Furthermore, our investigations revealed that NSCLC patients with elevated CASP3 levels showed increased expression of PD‐L2 (Figure 12C), a protein predominantly expressed by certain immune cells like macrophages and dendritic cells. This evidence concerns the gene PDCD1LG2 and non-small cell lung carcinoma.